Robert H Lee, postdoctoral fellow has been selected by the American Society of Hematology (ASH) to receive one of ASH’s most prestigious research award programs, the ASH Scholar Award. This award financially supports fellows to junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators. Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the new Fellow to Faculty Scholars level, or $150,000 for the Junior Faculty level over a two- to three-year period. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. Robert Lee’s area of interest includes the utility of platelet transfusion in various genetic and drug-induced bleeding disorders.
“I am incredibly honored to have received the ASH Scholar Award. Funding from ASH gives me the opportunity to continue this exciting research with the ultimate goal of translating our findings to improve patient care,” stated Dr. Robert H. Lee.
“For many scientists, attaining early funding for their research is a turning point, not only providing financial support but also showing that ASH believes in their potential to make impactful discoveries,” said 2020 ASH President Stephanie Lee, MD, MPH of Fred Hutchinson Cancer Research Center. “For more than 30 years now, ASH has been supporting fellows and early career faculty with Scholar Awards. Recipients of these prestigious awards have gone on to distinguished careers, receiving more than $1 billion from various funding institutions and becoming leaders in our field. Congratulations to all the Awardees.”
The American Society of Hematology (ASH) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention
of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online, as well as the newly launched, online, peer-reviewed open-access journal, Blood Advances.